Cargando…

Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk

Compared with other subgroups of breast cancer, triple negative breast cancer (TNBC) is considered to be the one with the greatest invasiveness and metastatic mobility, and the highest recurrence rate. Considering the lack of predictive markers for TNBC, we aimed to examine the contribution of excis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Chia-Wen, Chang, Wen-Shin, Shen, Te-Chun, Su, Chen-Hsien, Wang, Hwei-Chung, Liu, Liang-Chih, Bau, Da-Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086438/ https://www.ncbi.nlm.nih.gov/pubmed/30096175 http://dx.doi.org/10.1371/journal.pone.0202112

Ejemplares similares

Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk
por: Liu, Liang-Chih, et al.
Publicado: (2014)

The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple negative breast cancer risk
por: Chang, Wen-Shin, et al.
Publicado: (2016)

Significant Contribution of DNA Repair Human 8-Oxoguanine DNA N-Glycosylase 1 Genotypes to Renal Cell Carcinoma
por: Chang, Wen-Shin, et al.
Publicado: (2020)

The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan
por: Huang, Chung-Yu, et al.
Publicado: (2018)

Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma
por: Chang, Wen-Shin, et al.
Publicado: (2019)

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
por: Pei, Jen-Sheng, et al.
Publicado: (2018)

Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan
por: Huang, Chung-Yu, et al.
Publicado: (2018)

Complementation of aprataxin deficiency by base excision repair enzymes
por: Çağlayan, Melike, et al.
Publicado: (2015)

The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2020)

Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer
por: Luo, Shan-Shan, et al.
Publicado: (2018)

Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer
por: Lee, Kevin J., et al.
Publicado: (2019)

X-Ray Repair Cross Complementing Protein 1 in Base Excision Repair
por: Hanssen-Bauer, Audun, et al.
Publicado: (2012)

Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer
por: Shen, Te-Chun, et al.
Publicado: (2019)

Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016)

Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
por: SONG, PENG, et al.
Publicado: (2015)

Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts
por: Çağlayan, Melike, et al.
Publicado: (2017)

Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan
por: Yang, Mei-Due, et al.
Publicado: (2011)

The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in Taiwan
por: Tsai, Chia-Wen, et al.
Publicado: (2023)

Impact of Mir196a-2 Genotypes on Colorectal Cancer Risk in Taiwan
por: Yueh, Te-Cheng, et al.
Publicado: (2023)

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers
por: Abdel-Fatah, Tarek M.A., et al.
Publicado: (2015)

Non-Homologous End-Joining Pathway Genotypes Significantly Associated with Nasopharyngeal Carcinoma Susceptibility
por: Tsai, Chia-Wen, et al.
Publicado: (2023)

Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan
por: Yang, Mei-Due, et al.
Publicado: (2017)

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A
por: Wang, Xiaozhu, et al.
Publicado: (2017)

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer
por: Aiello, Marco Maria, et al.
Publicado: (2020)

Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2021)

Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan
por: Wang, Bo-Ren, et al.
Publicado: (2023)

Association of Alpha B-Crystallin Genotypes with Oral Cancer Susceptibility, Survival, and Recurrence in Taiwan
por: Bau, Da-Tian, et al.
Publicado: (2011)

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

The Association of Methylenetetrahydrofolate Reductase Genotypes with the Risk of Childhood Leukemia in Taiwan
por: Pei, Jen-Sheng, et al.
Publicado: (2015)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study
por: Kulkarni, Spoorti, et al.
Publicado: (2020)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
por: Peng, Haiying, et al.
Publicado: (2018)

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
por: Rao, Devika, et al.
Publicado: (2019)

Novel genetic variants in long non-coding RNA MEG3 are associated with the risk of asthma
por: Chiu, Kuo-Liang, et al.
Publicado: (2023)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer
por: Shen, Te-Chun, et al.
Publicado: (2017)

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
por: Tiwari, Prashant Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_759nsljbsmo4h3satbotrse7tu